<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33373340</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1731</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>4</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Archivos de cardiologia de Mexico</Title><ISOAbbreviation>Arch Cardiol Mex</ISOAbbreviation></Journal><ArticleTitle>[Shortening in the Tp-e/QTc ratio after angioplasty in patients with acute coronary syndrome].</ArticleTitle><Pagination><StartPage>452</StartPage><EndPage>466</EndPage><MedlinePgn>452-466</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/ACM.20000010</ELocationID><Abstract><AbstractText Label="OBJETIVO">La dispersi&#xf3;n transmural de la repolarizaci&#xf3;n ventricular (DTMRV) es un factor de riesgo para muerte en pacientes con s&#xed;ndrome isqu&#xe9;mico coronario agudo (SICA). Con el objetivo de conocer el efecto de la realizaci&#xf3;n de angioplastia sobre la DTMRV, se estudi&#xf3; la relaci&#xf3;n Tp-f/QTc en pacientes con SICA sometidos a angioplastia.</AbstractText><AbstractText Label="M&#xc9;TODO">Se dise&#xf1;&#xf3; un estudio observacional, retrospectivo y descriptivo. Se incluyeron 150 pacientes (N = 150) con diagn&#xf3;stico de SICA. Se valor&#xf3; la relaci&#xf3;n Tp-f/QTc inicial y se evalu&#xf3; su acortamiento posangioplastia. Como objetivo secundario, se compar&#xf3; la asociaci&#xf3;n de dichos cambios en la relaci&#xf3;n Tp-f/QTc con la mortalidad cardiovascular y los eventos adversos cardiovasculares.</AbstractText><AbstractText Label="RESULTADOS">El promedio en la relaci&#xf3;n Tp-f/QTc inicial fue de 0.2529, mientras que posangioplastia fue de 0.2397. Por medio de prueba de rangos de Wilcoxon se evidenci&#xf3; un descenso significativo en la relaci&#xf3;n Tp-f/QTc posterior a la angioplastia, con un valor Z de -2.051 y una p &lt; 0.04. En el an&#xe1;lisis secundario se encontr&#xf3; que una Tp-f/QTc &#x2265; 0.29 posangioplastia es factor de riesgo para presentaci&#xf3;n de los siguientes eventos adversos: muerte intrahospitalaria (7.4 vs 0%; p &lt; 0.003), nuevo SICA en seguimiento a 1 a&#xf1;o (25.9 vs. 18.5%; p &lt; 0.006) y reintervenci&#xf3;n en seguimiento a 1 a&#xf1;o (29.6 vs. 15.0%; p &lt; 0.002).</AbstractText><AbstractText Label="CONCLUSIONES">Existe un acortamiento significativo en la relaci&#xf3;n Tp-f/QTc posangioplastia en pacientes con SICA. Esta medida de la DTMRV puede servir como un predictor de muerte intrahospitalaria, eventos cardiovasculares y reintervenci&#xf3;n a 1 a&#xf1;o en pacientes con SICA tratados con angioplastia.</AbstractText><AbstractText Label="OBJECTIVE">Transmural Dispersion of Repolarization (TDR) is a Risk factor for Death in patients with Acute Coronary &#xad;Syndrome (ACS). In order to know the effect of angioplasty on TDR, the Tp-e/QTc ratio was studied in patients with ACS undergoing angioplasty.</AbstractText><AbstractText Label="METHOD">An observational, retrospective and descriptive study was designed. 150 patients (N = 150) with diagnosis of ACS were included. The initial Tp-e/QTc ratio was assessed and then its post-angioplasty shortening was evaluated. As a secondary objective, we compared the association of these Tp-e/QTc ratio changes with cardiovascular mortality and cardiovascular adverse events.</AbstractText><AbstractText Label="RESULTS">The average in the initial Tp-e/QTc ratio was 0.2529, while post-angioplasty was 0.2397. Through a Wilcoxon rage test, a significant decrease in the Tp-e/QTc ratio after angioplasty was observed, with a Z value of &#x2212;2.051 and p &lt; 0.04. In the secondary analysis, it was found that a Tp-e/QTc &#x2265; 0.29 post-angioplasty is a risk factor for presenting the following adverse events: in-hospital death (7.4 vs. 0%; p &lt; 0.003), new ACS in 1-year follow-up (25.9 vs. 18.5%; p &lt; 0.006), and reintervention in 1-year follow up (29.6 vs. 15%; p &lt; 0.002).</AbstractText><AbstractText Label="CONCLUSIONS">There is a significant shortening in the Tp-e/QTc ratio post-angioplasty in patients with ACS. This measure of TDR can serve as a predictor of in-hospital death, cardiovascular events and 1-year reintervention in patients with ACS treated initially by angioplasty.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2020 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rom&#xe1;n-Guzm&#xe1;n</LastName><ForeName>Rodolfo M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital San Jos&#xe9; Tec Salud.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joya-Harrison</LastName><ForeName>Jorge A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital San Jos&#xe9; Tec Salud.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarrete-L&#xf3;pez</LastName><ForeName>Claudia A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital San Jos&#xe9; Tec Salud.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadena-Payton</LastName><ForeName>Arturo M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Instituto de Cardiolog&#xed;a, Centro M&#xe9;dico Zambrano Hellion, Escuela de Medicina del Tecnol&#xf3;gico de Monterrey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Segura-Ibarra</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Escuela de Ingenier&#xed;a y Ciencias, Tecnol&#xf3;gico de Monterrey. Monterrey, Nuevo Le&#xf3;n, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdovinos-Ch&#xe1;vez</LastName><ForeName>Salvador B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital San Jos&#xe9; Tec Salud.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Acortamiento en la relaci&#xf3;n Tp-f/QTc tras angioplastia en pacientes con s&#xed;ndrome isqu&#xe9;mico coronario agudo.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Arch Cardiol Mex</MedlineTA><NlmUniqueID>101126728</NlmUniqueID><ISSNLinking>1665-1731</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D054058" MajorTopicYN="N">Acute Coronary Syndrome</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017130" MajorTopicYN="N">Angioplasty</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACS</Keyword><Keyword MajorTopicYN="N">DTMRV</Keyword><Keyword MajorTopicYN="N">SICA</Keyword><Keyword MajorTopicYN="N">TDR</Keyword><Keyword MajorTopicYN="N">Tp-e</Keyword><Keyword MajorTopicYN="N">Tp-f</Keyword><Keyword MajorTopicYN="N">Tp-f/QT</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>17</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33373340</ArticleId><ArticleId IdType="doi">10.24875/ACM.20000010</ArticleId><ArticleId IdType="pii">j90/4/452</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26970258</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0705</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology</Title><ISOAbbreviation>Ultrasound Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis of persistent left superior vena cava on prenatal ultrasound: associated anomalies, diagnostic accuracy and postnatal outcome.</ArticleTitle><Pagination><StartPage>701</StartPage><EndPage>708</EndPage><MedlinePgn>701-708</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/uog.15914</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To quantify the prevalence of chromosomal anomalies in fetuses with persistent left superior vena cava (PLSVC), assess the strength of the association between PLSVC and coarctation of the aorta and ascertain the diagnostic accuracy of antenatal ultrasound in correctly identifying isolated cases of PLSVC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">MEDLINE, EMBASE, CINHAL and the Cochrane databases were searched from the year 2000 onwards using combinations of keywords 'left superior vena cava' and 'outcome'. Two authors reviewed all abstracts independently. Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale for cohort studies. The rates of the following outcomes were analyzed: chromosomal abnormalities; associated intracardiac anomalies (ICAs) and extracardiac anomalies (ECAs) diagnosed prenatally; additional ICAs and ECAs detected only at postnatal imaging or clinical evaluation but missed at prenatal imaging; and association of PLSVC and coarctation of the aorta. Meta-analyses of proportions were used to combine data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 2708 articles were identified and 13 (n&#x2009;=&#x2009;501) were included in the systematic review. Associated ICAs and ECAs were detected at the prenatal ultrasound examination or at a follow-up assessment in 60.7% (95% CI, 44.2-75.9%) and 37.8% (95% CI, 31.0-44.8%) of cases, respectively. Chromosomal anomalies occurred in 12.5% (95% CI, 9.0-16.4%) of cases in the overall population of fetuses with PLSVC and in 7.0% (95% CI, 2.7-13.0%) of isolated cases. Additional ICAs and ECAs were detected only after birth and missed at ultrasound in 2.4% (95% CI, 0.5-5.8%) and 6.7% (95% CI, 2.2-13.2%) of cases, respectively. Coarctation of the aorta was associated with isolated PLSVC in 21.3% (95% CI, 13.6-30.3%) of cases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PLSVC is commonly associated with ICAs, ECAs and chromosomal anomalies. Fetuses with isolated PLSVC should be followed up throughout pregnancy in order to rule out coarctation of the aorta. As most of the data in this review were derived from high-risk pregnancies, the rate of associated abnormalities is likely to be higher than that in the general population of fetuses with PLSVC, for which more data are needed. Revisi&#xf3;n sistem&#xe1;tica y metaan&#xe1;lisis de la persistencia de la vena cava superior izquierda en la ecograf&#xed;a prenatal: anomal&#xed;as asociadas, precisi&#xf3;n del diagn&#xf3;stico y resultado postnatal RESUMEN OBJETIVOS: Cuantificar la prevalencia de anomal&#xed;as cromos&#xf3;micas en fetos con vena cava superior izquierda persistente (VCSIP), evaluar la solidez de la asociaci&#xf3;n entre la VCSIP y la coartaci&#xf3;n a&#xf3;rtica, y determinar la precisi&#xf3;n del diagn&#xf3;stico de la ecograf&#xed;a prenatal como m&#xe9;todo para identificar correctamente casos aislados de VCSIP. M&#xc9;TODOS: Se busc&#xf3; en las bases de datos de MEDLINE, EMBASE, CINHAL y Cochrane art&#xed;culos publicados desde el a&#xf1;o 2000 en adelante, usando combinaciones de las palabras clave "vena cava superior izquierda" y "resultado". Dos de los autores revisaron de forma independiente todos los res&#xfa;menes encontrados. La evaluaci&#xf3;n de calidad de los estudios incluidos se realiz&#xf3; mediante la escala Newcastle-Ottawa para estudios de cohortes. Se analizaron las tasas de los siguientes resultados: anomal&#xed;as cromos&#xf3;micas; anomal&#xed;as intracard&#xed;acas (AIC) y anomal&#xed;as extracard&#xed;acas (AEC) asociadas diagnosticadas prenatalmente; AIC y AEC adicionales detectadas s&#xf3;lo en ecograf&#xed;as postnatales o mediante evaluaci&#xf3;n cl&#xed;nica, pero no observadas en ecograf&#xed;as prenatales; y la asociaci&#xf3;n entre la VCSIP y la coartaci&#xf3;n a&#xf3;rtica. Se utiliz&#xf3; un meta-an&#xe1;lisis de proporciones para combinar los datos.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">En total, se identificaron 2708 art&#xed;culos y se incluyeron 13 (n&#x2009;=&#x2009;501) en la revisi&#xf3;n sistem&#xe1;tica. En la ecograf&#xed;a prenatal o en una revisi&#xf3;n de seguimiento se detectaron AIC y AEC asociadas en el 60,7% (IC 95%, 44,2-75,9%) y el 37,8% (IC 95%, 31,0-44,8%) de los casos, respectivamente. Se produjeron anomal&#xed;as cromos&#xf3;micas en el 12,5% (IC 95%, 9,0-16,4%) de los casos en la poblaci&#xf3;n general de fetos con VCSIP y en el 7,0% (IC 95%, 2,7-13,0%) de casos aislados. Las AIC y AEC adicionales s&#xf3;lo se detectaron despu&#xe9;s del nacimiento y en el 6,7% (IC 95%, 2,2-13,2%) de los casos, respectivamente. La coartaci&#xf3;n a&#xf3;rtica se encontr&#xf3; asociada con la VCSIP aislada en un 21,3% (IC 95%, 13,6-30,3%) de los casos.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">La VCSIP est&#xe1; com&#xfa;nmente asociada a AIC, AEC y anomal&#xed;as cromos&#xf3;micas. Los fetos con VCSIP aislada deben ser objeto de seguimiento durante todo el embarazo, con el fin de descartar la coartaci&#xf3;n a&#xf3;rtica. Como la mayor&#xed;a de los datos de esta revisi&#xf3;n proceden de embarazos de alto riesgo, es probable que la tasa de anomal&#xed;as asociadas sea m&#xe1;s alta que la de la poblaci&#xf3;n general de fetos con VCSIP, por lo que se necesitan m&#xe1;s datos.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 ISUOG. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gustapane</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, SS. Annunziata Hospital, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leombroni</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, SS. Annunziata Hospital, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fetal Medicine Unit, Division of Developmental Sciences, St George's University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giacci</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, SS. Annunziata Hospital, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrone</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, SS. Annunziata Hospital, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bascietto</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, SS. Annunziata Hospital, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Universit&#xe0; di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acharya</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Women's Health and Perinatology Research Group, Department of Clinical Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, University Hospital of Northern Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liberati</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, SS. Annunziata Hospital, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Antonio</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Women's Health and Perinatology Research Group, Department of Clinical Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, University Hospital of Northern Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ultrasound Obstet Gynecol</MedlineTA><NlmUniqueID>9108340</NlmUniqueID><ISSNLinking>0960-7692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001017" MajorTopicYN="N">Aortic Coarctation</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002869" MajorTopicYN="N">Chromosome Aberrations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016216" MajorTopicYN="N">Ultrasonography, Prenatal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054079" MajorTopicYN="N">Vascular Malformations</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014683" MajorTopicYN="N">Vena Cava, Superior</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">congenital heart disease</Keyword><Keyword MajorTopicYN="N">fetal echocardiography</Keyword><Keyword MajorTopicYN="N">persistent left superior vena cava</Keyword><Keyword MajorTopicYN="N">prenatal diagnosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26970258</ArticleId><ArticleId IdType="doi">10.1002/uog.15914</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>